Altus Strategies PLC Q&A with CEO Steve Poulton (LON:ALS)
11 September 2018
Scholar Rock Holding Corporation (NASDAQ: SRRK) is increasingly becoming a focal point for investors looking to capitalize on the innovative strides being made in the biotechnology sector. With a market..
Immunovant, Inc. (NASDAQ: IMVT), a promising player in the biotechnology sector, has captured investor attention with its potential for significant upside. With a market capitalization of $5.38 billion, this clinical-stage..
Belite Bio, Inc (NASDAQ: BLTE) stands as a promising prospect in the biotechnology sector, captivating investor interest with its robust clinical pipeline and a potential upside of 18.08% based on..
Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and robust market position. With a market capitalization of $1.73..
LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking exposure to innovative medical technology. With..
MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector. Specializing in innovative treatments for inflammatory skin and joint diseases, MoonLake’s..
GeneDx Holdings Corp. (NASDAQ: WGS) is capturing investor attention across the healthcare sector with its robust position in the diagnostics and research industry. With a market capitalization of $2.77 billion,..
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector focused on specialty and generic drug manufacturing, stands as an intriguing prospect for investors seeking potential growth within..
Investors with an appetite for potential growth in the biotech sector should consider Protagonist Therapeutics, Inc. (NASDAQ: PTGX). With a market capitalization of $6.17 billion, this Newark, California-based company is..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon of innovation in the biotechnology industry, particularly in the niche of rare and ultra-rare genetic diseases. With a market cap of..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving a niche for itself in the healthcare sector, particularly within the medical devices industry. This San Jose-based company is known for its innovative..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector, offering investors a tantalizing opportunity with its potential upside of 37.15%. As a commercial-stage biopharmaceutical company, Catalyst focuses..
Warby Parker Inc. (WRBY), a notable player in the healthcare sector, is garnering attention with its promising investment outlook. Known for its innovative approach to selling eyewear products, this New..
Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a key player in the healthcare sector, is making waves among investors with its strong foothold in the medical care facilities industry. Headquartered..
In the ever-evolving landscape of biotechnology, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with its ambitious innovations in immunotherapy. Based in San Diego, California, ImmunityBio is at the forefront of developing..
Metsera, Inc. (MTSR) is a clinical-stage biotechnology company making strides in the healthcare sector, especially in the fight against obesity and related metabolic disorders. Incorporated in 2022 and currently a..
Surgery Partners, Inc. (NASDAQ: SGRY) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the company boasts a comprehensive..
ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector, specializes in the development, manufacturing, and distribution of essential medical instruments and supplies. With a market cap of..
Zai Lab Limited (NASDAQ: ZLAB), a notable player in the biotechnology sector, is capturing attention with its promising growth potential and strategic collaborations. With a market capitalization of $2.12 billion,..
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company specializing in innovative immunotherapies, is currently navigating a complex financial landscape while advancing its promising clinical pipeline. With a market capitalization of $6.7..
